IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
18 hedge funds and large institutions have $1.54M invested in Interpace Biosciences, Inc. Common Stock in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$5K | |
| 2 | +$3K | |
| 3 | +$1.43K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1K |
Top Sellers
| 1 | -$77K | |
| 2 | -$40K | |
| 3 | -$15.8K | |
| 4 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$9.15K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$6K |